---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-090366"
form_type: "8-K"
ticker: "INMB"
cik: "0001711754"
company_name: "Inmune Bio, Inc."
filed_at: "2024-10-24T23:59:59+00:00"
generated_at: "2026-05-30T10:33:39.922060+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# INmune Bio schedules Q3 2024 earnings call for Oct 31 at 4:30pm EDT

## Summary
- Press release issued Oct 24, 2024 announcing conference call date.
- Call on Thursday, October 31, 2024 at 4:30pm ET to discuss Q3 results and corporate update.
- Dial-in: 1-800-343-4136 (US), 1-203-518-9843 (intl); Conference ID: INMUNE.
- Webcast and replay available; transcript expected within 24 hours of call.

## SEC filing metadata
- accession: 0001213900-24-090366
- form_type: 8-K
- ticker: INMB
- cik: 0001711754
- company_name: Inmune Bio, Inc.
- filed_at: 2024-10-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711754/000121390024090366/0001213900-24-090366-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711754/000121390024090366/ea0218524-8k_inmune.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-090366
- JSON: https://secwatch.observer/filing/0001213900-24-090366.json
- Plain text: https://secwatch.observer/filing/0001213900-24-090366.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.